Outcomes
SECONDARY, RECURRENCE, COMPLICATIONS
The primary outcome is to evaluate the patients’ quality of life at 1 year of follow-up. The secondary aim is to assess the rate of clinical recurrence, complications, and costs of both treatments at 1 year of follow-up.Main variable: percentage of patients with an increase of more than 30 points in the IBDQ-32 quality of life index. Secondary variables: percentage of patients with clinical recurrence, percentage of complications, and costs.